NSEAction(s) taken or orders passed19 Jun 2026 · 19 Jun 2026, 05:53 pm

Action(s) taken or orders passed

Anuh Pharma Limited · ANUHPHR

✦ AI Summary

Anuh Pharma Limited has informed the stock exchanges about receiving a Demand Order and a Penalty Order from the Income Tax Department. These orders, issued under Sections 156 and 270 of the Income Tax Act, 1961, are a result of a scrutiny assessment for the Assessment Year 2020-21. Crucially, the announcement does not disclose the monetary value of the demand or penalty. Therefore, investors cannot currently ascertain the specific financial impact or potential liability on the company.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anuh Pharma Limited has informed the Exchange about orders passed regarding receipt of Demand Order under Section 156 and Penalty Order under Section 270 of the Income Tax Act, 1961.

Attachments (1)

📄

ANUHNSE_19062026175252_Regulation_30_Income_Tax_Order_f.pdf

pdf

Download →
View document text
Date: 19th June, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Mumbai - 400001 Bandra-Kurla Complex, Bandra (E), Mumbai - 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR’) Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR”), we hereby inform that the Income Tax Department (Assessment Unit) has issued a Tax Demand Order under Section 156 and Penalty Order under Section 270 of the Income Tax Act, 1961, against Anuh Pharma Limited. The said order has been passed in respect of the Scrutiny Assessment for Assessment Year 2020-21 in relation to an Income Tax matter. The details, as required under Para A (20) of Part A of Schedule III to the SEBI LODR, are provided below: Sr. Particulars Details 1. Name of the Authority Income Tax Department, Assessment Unit 2. Nature and Details of the action(s) Penalty Order under section 270A taken or order(s) passed 3. Date of receipt of direction or order, 18th June, 2026 at IST 23:29 Hrs. including any ad-interim or interim orders, or any other communication from the authority 4. Details of the violation(s) / On account of disallowances of certain contravention(s) committed or deductions claimed under various alleged to be committed provision of the Income Tax Act. 5. Impact on financial, operation or Rs. 17,46,026/- which includes Penalty other activities of the listed entity, u/s 270A(9) r.w.s. 270A(8) of Income Tax quantifiable in monetary terms to Act. The company is in process of filing an the extent possible appeal before the Higher Appellate Forums, against the said order within the prescribed timelines. The Company believes that it has adequate factual and legal grounds to reasonably substantiate its position in the matter. As such, there is no impact on financial operations or other activities of the Company. You are requested to take note of the above. This disclosure is also being uploaded on the website of the Company at www.anuhpharma.com Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Place: Mumbai